Skip to main content

Table 1 Demographics and concomitant medication

From: Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

 

Overall

40 ml EcN

20 ml EcN

10 ml EcN

Placebo

Age (years)

41.8 ± 12.7

40.5 ± 14.3

42.3 ± 12.0

37.5 ± 9.0

47.4 ± 13.8

Gender (m : f)

49 : 39

13 : 10

13 : 10

11 : 11

12 : 8

Smoking

3/88

2/23

1/23

0/22

0/20

Previous colonic surgery

-

-

2/23

-

1/20

Antidiarrhoeal, antiinflammatory and/or antiinfective medication

53/88

60.2%

15/23

65.2%

11/23

47.8%

15/22

68.2%

12/20

60.0%

Systemic corticosteroids

14/88

15.9%

3/23

13.0%

3/23

13.0%

6/22

27.3%

2/20

10.0%